US Stock MarketDetailed Quotes

GTBP GT Biopharma

Watchlist

2.1600
-0.0900-4.00%

Trading Sep 18 10:26 ET

4.83MMarket Cap-276P/E (TTM)

GT Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-82.74%-3.54M

-43.26%-4.16M

41.83%-8.85M

52.37%-2.05M

32.69%-1.96M

30.55%-1.94M

44.28%-2.91M

2.49%-15.22M

-16.01%-4.3M

25.73%-2.92M

Net income from continuing operations

-86.24%-3.71M

-898.24%-2.27M

63.62%-7.6M

46.96%-2.96M

64.89%-2.42M

33.13%-1.99M

95.83%-227K

64.00%-20.88M

69.02%-5.58M

-26.19%-6.88M

Operating gains losses

91.65%-117K

80.97%-658K

-3,462.67%-5.34M

98.55%-1K

-736.21%-485K

-27,920.00%-1.4M

-19,105.56%-3.46M

28.91%-150K

58.93%-69K

88.45%-58K

Other non cash items

3.85%27K

4.00%26K

-13.85%112K

----

-93.33%26K

-97.13%25K

-81.94%130K

----

Change In working capital

-85.91%147K

-3,322.50%-1.37M

191.75%1.83M

-88.14%376K

113.13%446K

257.79%1.04M

96.36%-40K

-125.05%-1.99M

-50.75%3.17M

-401.96%-3.4M

-Change in prepaid assets

654.55%61K

-62.50%6K

-116.54%-21K

-208.82%-37K

-91.79%11K

-104.76%-11K

105.88%16K

-27.01%127K

132.38%34K

682.61%134K

-Change in payables and accrued expense

-89.27%116K

-4,544.83%-1.35M

196.65%1.96M

-83.74%525K

110.91%385K

221.32%1.08M

96.54%-29K

-126.14%-2.03M

-50.63%3.23M

-407.49%-3.53M

-Change in other current assets

----

--24K

-Change in other current liabilities

-11.11%-30K

-3.70%-28K

-34.88%-116K

-41.67%-34K

-12.00%-28K

-12.50%-27K

-107.69%-27K

---86K

---24K

---25K

Cash from discontinued investing activities

Operating cash flow

-82.74%-3.54M

-43.26%-4.16M

41.83%-8.85M

52.37%-2.05M

32.69%-1.96M

30.55%-1.94M

44.28%-2.91M

2.49%-15.22M

-16.01%-4.3M

25.73%-2.92M

Investing cash flow

Cash flow from continuing investing activities

195.78%7.86M

172.03%5.03M

-116.54%-2.01M

-93.63%478K

7,280.00%1.85M

145.79%2.66M

-297.82%-6.99M

152.71%12.15M

150.95%7.51M

100.10%25K

Net investment purchase and sale

195.78%7.86M

172.03%5.03M

-116.54%-2.01M

-93.63%478K

7,280.00%1.85M

145.79%2.66M

-297.82%-6.99M

152.71%12.15M

150.95%7.51M

100.10%25K

Cash from discontinued investing activities

Investing cash flow

195.78%7.86M

172.03%5.03M

-116.54%-2.01M

-93.63%478K

7,280.00%1.85M

145.79%2.66M

-297.82%-6.99M

152.71%12.15M

150.95%7.51M

100.10%25K

Financing cash flow

Cash flow from continuing financing activities

2.98M

2,898.21%6.27M

6.27M

-100.53%-224K

-1K

Net common stock issuance

--2.98M

--0

2,898.21%6.27M

--0

--6.27M

-100.91%-224K

---1K

--0

Cash from discontinued financing activities

Financing cash flow

--2.98M

--0

2,898.21%6.27M

--0

--6.27M

-100.53%-224K

---1K

--0

Net cash flow

Beginning cash position

-4.65%1.95M

-80.98%1.08M

-36.75%5.67M

7.42%2.65M

-48.36%2.77M

-71.93%2.05M

-36.75%5.67M

69.30%8.97M

-74.54%2.47M

-86.44%5.36M

Current changes in cash

910.94%7.3M

124.01%871K

-39.35%-4.59M

-148.92%-1.57M

95.89%-119K

137.45%722K

-115.64%-3.63M

-189.78%-3.3M

549.16%3.21M

90.30%-2.89M

End cash Position

234.26%9.25M

-4.65%1.95M

-80.98%1.08M

7.42%2.65M

-48.36%2.77M

-71.93%2.05M

-36.75%5.67M

-74.54%2.47M

Free cash flow

-82.74%-3.54M

-43.26%-4.16M

41.83%-8.85M

52.37%-2.05M

32.69%-1.96M

30.55%-1.94M

44.28%-2.91M

2.49%-15.22M

-16.01%-4.3M

25.73%-2.92M

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-82.74%-3.54M	-43.26%-4.16M	41.83%-8.85M	52.37%-2.05M	32.69%-1.96M	30.55%-1.94M	44.28%-2.91M	2.49%-15.22M	-16.01%-4.3M	25.73%-2.92M
Net income from continuing operations	-86.24%-3.71M	-898.24%-2.27M	63.62%-7.6M	46.96%-2.96M	64.89%-2.42M	33.13%-1.99M	95.83%-227K	64.00%-20.88M	69.02%-5.58M	-26.19%-6.88M
Operating gains losses	91.65%-117K	80.97%-658K	-3,462.67%-5.34M	98.55%-1K	-736.21%-485K	-27,920.00%-1.4M	-19,105.56%-3.46M	28.91%-150K	58.93%-69K	88.45%-58K
Other non cash items	3.85%27K	4.00%26K	-13.85%112K	----	----	-93.33%26K	-97.13%25K	-81.94%130K	----	----
Change In working capital	-85.91%147K	-3,322.50%-1.37M	191.75%1.83M	-88.14%376K	113.13%446K	257.79%1.04M	96.36%-40K	-125.05%-1.99M	-50.75%3.17M	-401.96%-3.4M
-Change in prepaid assets	654.55%61K	-62.50%6K	-116.54%-21K	-208.82%-37K	-91.79%11K	-104.76%-11K	105.88%16K	-27.01%127K	132.38%34K	682.61%134K
-Change in payables and accrued expense	-89.27%116K	-4,544.83%-1.35M	196.65%1.96M	-83.74%525K	110.91%385K	221.32%1.08M	96.54%-29K	-126.14%-2.03M	-50.63%3.23M	-407.49%-3.53M
-Change in other current assets	----	----	----	----	----	----	----	----	----	--24K
-Change in other current liabilities	-11.11%-30K	-3.70%-28K	-34.88%-116K	-41.67%-34K	-12.00%-28K	-12.50%-27K	-107.69%-27K	---86K	---24K	---25K
Cash from discontinued investing activities
Operating cash flow	-82.74%-3.54M	-43.26%-4.16M	41.83%-8.85M	52.37%-2.05M	32.69%-1.96M	30.55%-1.94M	44.28%-2.91M	2.49%-15.22M	-16.01%-4.3M	25.73%-2.92M
Investing cash flow
Cash flow from continuing investing activities	195.78%7.86M	172.03%5.03M	-116.54%-2.01M	-93.63%478K	7,280.00%1.85M	145.79%2.66M	-297.82%-6.99M	152.71%12.15M	150.95%7.51M	100.10%25K
Net investment purchase and sale	195.78%7.86M	172.03%5.03M	-116.54%-2.01M	-93.63%478K	7,280.00%1.85M	145.79%2.66M	-297.82%-6.99M	152.71%12.15M	150.95%7.51M	100.10%25K
Cash from discontinued investing activities
Investing cash flow	195.78%7.86M	172.03%5.03M	-116.54%-2.01M	-93.63%478K	7,280.00%1.85M	145.79%2.66M	-297.82%-6.99M	152.71%12.15M	150.95%7.51M	100.10%25K
Financing cash flow
Cash flow from continuing financing activities	2.98M	0	2,898.21%6.27M	0	0	0	6.27M	-100.53%-224K	-1K	0
Net common stock issuance	--2.98M	--0	2,898.21%6.27M	--0	--0	--0	--6.27M	-100.91%-224K	---1K	--0
Cash from discontinued financing activities
Financing cash flow	--2.98M	--0	2,898.21%6.27M	--0	--0	--0	--6.27M	-100.53%-224K	---1K	--0
Net cash flow
Beginning cash position	-4.65%1.95M	-80.98%1.08M	-36.75%5.67M	7.42%2.65M	-48.36%2.77M	-71.93%2.05M	-36.75%5.67M	69.30%8.97M	-74.54%2.47M	-86.44%5.36M
Current changes in cash	910.94%7.3M	124.01%871K	-39.35%-4.59M	-148.92%-1.57M	95.89%-119K	137.45%722K	-115.64%-3.63M	-189.78%-3.3M	549.16%3.21M	90.30%-2.89M
End cash Position	234.26%9.25M	-4.65%1.95M	-80.98%1.08M	-80.98%1.08M	7.42%2.65M	-48.36%2.77M	-71.93%2.05M	-36.75%5.67M	-36.75%5.67M	-74.54%2.47M
Free cash flow	-82.74%-3.54M	-43.26%-4.16M	41.83%-8.85M	52.37%-2.05M	32.69%-1.96M	30.55%-1.94M	44.28%-2.91M	2.49%-15.22M	-16.01%-4.3M	25.73%-2.92M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data